Bombesin Analogue-Mediated Delivery Preferentially Enhances the Cytotoxicity of a Mitochondria-Disrupting Peptide in Tumor Cells

PLoS ONE - United States
doi 10.1371/journal.pone.0057358
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Chondroitin Sulfate as a Molecular Portal That Preferentially Mediates the Apoptotic Killing of Tumor Cells by Penetratin-Directed Mitochondria-Disrupting Peptides

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Disrupting G6pd-Mediated Redox Homeostasis Enhances Chemosensitivity in Colorectal Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2017English

Sulforaphane Synergistically Enhances the Cytotoxicity of Arsenic Trioxide in Multiple Myeloma Cells via Stress-Mediated Pathways

Oncology Reports
MedicineCancer ResearchOncology
2012English

Tumor-Targeting Nanodelivery Enhances the Anticancer Activity of a Novel Quinazolinone Analogue

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Thalidomide Enhances Cyclophosphamide and Dexamethasone-Mediated Cytotoxicity Towards Cultured Chronic Lymphocytic Leukaemia Cells

Oncology Reports
MedicineCancer ResearchOncology
2010English

Lapatinib Enhances Trastuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity via Upregulation of HER2 in Malignant Mesothelioma Cells

Oncology Reports
MedicineCancer ResearchOncology
2015English

Celastrol Synergistically Enhances Temozolomide Cytotoxicity in Melanoma Cells

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2009English

Connexin 43 Enhances the Cisplatin-Induced Cytotoxicity in Mesothelioma Cells

2012English

Sorafenib Analogue SC-60 Induces Apoptosis Through the SHP-1/STAT3 Pathway and Enhances Docetaxel Cytotoxicity in Triple-Negative Breast Cancer Cells

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy